These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12592090)

  • 1. Cutaneous recall reactions with systemic fluorouracil.
    Kirkup ME; Narayan S; Kennedy CT
    Dermatology; 2003; 206(2):175-6. PubMed ID: 12592090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inflammatory effect of systemic fluorouracil in actinic keratosis.
    Nabai H; Mohindra R; Mehregan D
    Cutis; 1999 Jul; 64(1):43-4. PubMed ID: 10431671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic toxicity from occlusive therapy with topical 5-fluorouracil: a case report and review of the literature.
    Sargen M; Wanat KA; Jambusaria A; Rosenbach M; Sobanko J; Miller CJ
    Dermatol Surg; 2012 Oct; 38(10):1756-9. PubMed ID: 22805044
    [No Abstract]   [Full Text] [Related]  

  • 4. Intermittent topical 5-fluorouracil is effective without significant irritation in the treatment of actinic keratoses but prolongs treatment duration.
    Labandeira J; Pereiro M; Valdés F; Toribio J
    Dermatol Surg; 2004 Apr; 30(4 Pt 1):517-20. PubMed ID: 15056141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does intermittent "pulse" topical 5-fluorouracil therapy allow destruction of actinic keratoses without significant inflammation?
    Epstein E
    J Am Acad Dermatol; 1998 Jan; 38(1):77-80. PubMed ID: 9448209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Painful scrotal dermatitis secondary to topical 5-fluorouracil.
    Yi JZ; Himes RS; Smith RJ; McKee PH; Roberts AA
    Dermatol Online J; 2021 Jun; 27(6):. PubMed ID: 34387061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical application of 5-fluorouracil 5 percent cream associated with severe neutropenia: discussion of a case and review of systemic reactions after topical treatment with 5-fluorouracil.
    Cohen PR
    Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil.
    Powers R; Gordon R; Roberts K; Kovach R
    Cutis; 2012 May; 89(5):225-8. PubMed ID: 22768435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy.
    Couch SM; Custer PL
    Ophthalmic Plast Reconstr Surg; 2012; 28(3):181-3. PubMed ID: 22460673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Photograph-Based Toxicity Score for Topical 5-Fluorouracil Cream Application.
    Pomerantz H; Korgavkar K; Lee KC; Lew R; Weinstock MA;
    J Cutan Med Surg; 2016 Sep; 20(5):458-66. PubMed ID: 27207349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of lip keratoses (actinic cheilitis) with topical fluorouracil.
    Epstein E
    Arch Dermatol; 1977 Jul; 113(7):906-8. PubMed ID: 879810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual serpentine hyperpigmentation associated with 5-fluorouracil. Case report and review of cutaneous manifestations associated with systemic 5-fluorouracil.
    Vukelja SJ; Bonner MW; McCollough M; Cobb PW; Gaule DA; Fanucchi PJ; Keeling JH
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 2):905-8. PubMed ID: 1837033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation of solar keratoses following systemic 5-fluorouracil.
    Bataille V; Cunningham D; Mansi J; Mortimer P
    Br J Dermatol; 1996 Sep; 135(3):478-80. PubMed ID: 8949450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
    Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
    Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses.
    Yentzer B; Hick J; Williams L; Inabinet R; Wilson R; Camacho FT; Russell GB; Feldman SR
    Arch Dermatol; 2009 Feb; 145(2):203-5. PubMed ID: 19221274
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical fluorouracil therapy for precancers and cancers of the skin.
    Cullen SI
    J Am Geriatr Soc; 1979 Dec; 27(12):529-35. PubMed ID: 159921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic evaluation of 0.5% and 5% fluorouracil topical cream in patients with actinic keratosis.
    Levy S; Furst K; Chern W
    Clin Ther; 2001 Jun; 23(6):908-20. PubMed ID: 11440290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.
    Jorizzo J; Weiss J; Furst K; VandePol C; Levy SF
    Arch Dermatol; 2004 Jul; 140(7):813-6. PubMed ID: 15262691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized pustular drug eruption caused by topical 5-fluorouracil.
    Nemer KM; Solus JF; Schaffer A; Rosman IS; Lee SJ
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28834062
    [No Abstract]   [Full Text] [Related]  

  • 20. Eczema herpeticum complicating topical 5-Fluorouracil therapy.
    Levesque SW; Hantash BM
    Dermatitis; 2012; 23(5):240-1. PubMed ID: 23010835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.